|
RBM15B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.755800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.059380E-01 |
| Normal-vs-Stage2 |
2.194600E-01 |
| Normal-vs-Stage3 |
1.930160E-02 |
| Normal-vs-Stage4 |
3.073800E-02 |
| Stage1-vs-Stage2 |
9.765200E-01 |
| Stage1-vs-Stage3 |
2.587600E-01 |
| Stage1-vs-Stage4 |
3.989200E-01 |
| Stage2-vs-Stage3 |
4.349000E-01 |
| Stage2-vs-Stage4 |
5.701000E-01 |
| Stage3-vs-Stage4 |
8.096000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.468300E-02 |
| Normal-vs-AfricanAmerican |
6.196000E-01 |
| Normal-vs-Asian |
1.550830E-01 |
| Caucasian-vs-AfricanAmerican |
5.035200E-01 |
| Caucasian-vs-Asian |
9.670600E-01 |
| AfricanAmerican-vs-Asian |
5.475000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.430300E-02 |
| Normal-vs-Female |
5.201600E-02 |
| Male-vs-Female |
8.925400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.279010E-01 |
| Normal-vs-Age(41-60Yrs) |
8.640000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.297500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.474400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.041800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.453200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.906600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.504200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.243600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.941600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.820100E-02 |
| Classical-VS-Follicular |
1.01290000054099E-07 |
| Classical-VS-Other |
2.220600E-01 |
| Classical-VS-Normal |
5.313000E-01 |
| Tall-VS-Follicular |
1.269390E-01 |
| Tall-VS-Other |
7.461200E-01 |
| Tall-VS-Normal |
5.904300E-02 |
| Follicular-VS-Other |
6.262800E-01 |
| Follicular-VS-Normal |
7.83020000000301E-05 |
| Other-VS-Normal |
1.769810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.470400E-02 |
| Normal-vs-N1 |
5.297500E-03 |
| N0-vs-N1 |
3.826000E-01 |
|
|
